title: [Reactivation of tuberculosis during dual therapy with pegylated interferon and ribavirin for chronic hepatitis C].
abstract: Hepatitis C viral infection can be associated with other infectious diseases including viral and bacterial infections such as tuberculosis. Mycobacterium tuberculosis infection may be latent for many years and revealed during an immunodeficiency state. The responsibility of antiviral treatment in the reactivation of tuberculosis is controversial. We report two cases of tuberculous reactivation during bitherapy with pegylated interferon and ribavirin for chronic hepatitis C. A rapid viral response was obtained in both cases. Tuberculous reactivation occurred at 12 and 13 weeks of antiviral treatment, respectively. Tuberculosis involved urinary tract in one patient and lymph nodes in the other. Antituberculous treatment was given and antiviral treatment maintained. The outcome of tuberculosis was favourable and a sustained viral response was obtained for both patients.
authors.affiliation: Service de gastroentérologie B, hôpital la Rabta, Tunis, Tunisie. dcneziha@yahoo.fr
authors.forename: N
authors.initials: N
authors.lastname: Belkahla
authors.forename: H
authors.initials: H
authors.lastname: Kchir
authors.forename: N
authors.initials: N
authors.lastname: Maamouri
authors.forename: H
authors.initials: H
authors.lastname: Ouerghi
authors.forename: F B
authors.initials: FB
authors.lastname: Hariz
authors.forename: S
authors.initials: S
authors.lastname: Chouaib
authors.forename: H
authors.initials: H
authors.lastname: Chaabouni
authors.forename: N B
authors.initials: NB
authors.lastname: Mami
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D014775:Virus Activation
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a